Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Inovio Pharmaceuticals, Inc. (INO) had Normalized Pre-Tax Income of $-23.52M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-23.52M |
|
-- |
|
-- |
|
$23.08M |
|
$-23.08M |
|
$-0.43M |
|
$-23.52M |
|
|
Normalized Pre-Tax Income |
$-23.52M |
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.08M |
|
$-22.36M |
|
38.83M |
|
38.83M |
|
$-0.61 |
|
$-0.61 |
|
| Balance Sheet Financials | |
$52.70M |
|
$3.09M |
|
$15.54M |
|
$68.24M |
|
$31.71M |
|
-- |
|
$8.00M |
|
$39.71M |
|
$28.53M |
|
$28.53M |
|
$28.53M |
|
36.72M |
|
| Cash Flow Statement Financials | |
$-47.69M |
|
$5.23M |
|
$0.99M |
|
$65.81M |
|
$24.35M |
|
$-41.46M |
|
$2.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-82.43% |
|
-82.43% |
|
-34.47% |
|
-82.43% |
|
$0.78 |
|
$-1.23 |
|
$-1.23 |
|